July 17, 2026 · 9 min read · by Foundily Team
Pre-Money vs Post-Money Valuation Explained
Post money valuation confuses more founders than any other term sheet line. See the formula, real 2025 benchmarks, and how to convert between the two.

TL;DR
- Post-money valuation = pre-money valuation + the new money raised. Get the order wrong and your ownership math is wrong too.
- Investor ownership = investment ÷ post-money, not investment ÷ pre-money — a mistake that quietly changes a founder's stake by several points.
- Carta's Q3 2025 data puts median seed pre-money at $16M and median Series A pre-money at $49.3M, both record highs — see the SAFE calculator to model your own round against them.
- A 409A valuation is a different number for a different job: it sets your common stock strike price for options, it doesn't set what investors pay — more in the ESOP guide.
Two numbers on a term sheet, one letter apart, and founders mix them up constantly: pre-money valuation and post-money valuation. Get the order of operations wrong and you'll misjudge exactly how much of your company you're giving away.
The rule is simple to state and easy to forget under pressure: post money valuation is the pre-money figure plus whatever new money is coming in. This post walks through the formula, shows what it means for an investor's actual ownership stake, and grounds it with real 2025 benchmark data for seed and Series A rounds — so you know not just how the maths works, but what numbers are typical right now.
The formula, stated plainly
Pre-money valuation is what the company is worth the moment before new investment lands. Post-money valuation is what it's worth the moment after. The relationship between them is addition, not negotiation:
Post-money valuation formula
That second line is where most confusion actually causes damage. Founders often divide the investment by the pre-money figure instead of the post-money figure, which overstates how much stock the investor should get. Divide by the wrong base and the cap table ends up wrong before the round even closes.
It helps to think of pre-money as a starting point and post-money as the closing balance. Nobody disputes that new cash makes the company worth more the moment it lands — the only question is how much more, and that's exactly what pre-money valuation is meant to capture before the round happens. Post-money simply records the after-state once the cheque clears.
A worked example
Say a startup agrees an $8,000,000 pre-money valuation and raises $2,000,000 in a priced round. Post-money is the sum of the two: $10,000,000. The investor's stake is the investment divided by that post-money figure, not the pre-money one.
$2,000,000 raised on an $8,000,000 pre-money valuation
Notice what that means for the founders' side too: they don't retain 100% minus 20% of the pre-money value, they retain 80% of the new $10,000,000 post-money company. It's the same 80%, but stating it against the right base avoids a second, subtler mistake — assuming your existing shares are worth the pre-money number divided by your old share count, when in fact the price per share for the round is set against the post-money capitalisation table, including any new option pool top-up. For a full breakdown of how a raise reshapes the table, see what is a cap table.
Why this trips founders up on term sheets specifically
The confusion gets worse once SAFEs enter the picture, because a SAFE's valuation cap doesn't behave like a pre-money number at all — it behaves like a post-money one. A $1,000,000 SAFE at an $8,000,000 post-money cap gives the investor 1,000,000 ÷ 8,000,000, or 12.5%, with no addition step required. Compare that to a priced round at an $8,000,000 pre-money valuation for the same $1,000,000, which works out to 1,000,000 ÷ 9,000,000, or 11.1%. Two term sheets can quote an identical '$8M' and hand over different amounts of the company. We've covered that specific gap in detail in SAFE vs priced round, and it's worth running your own numbers through the SAFE calculator before you agree to a cap, since the definitions of pre-money SAFE and valuation cap are easy to conflate under deal pressure.
Where the pre-money number actually comes from
Unlike a public company's share price, a startup's pre-money valuation isn't observed on a market — it's negotiated. Investors typically triangulate using a mix of startup valuation methods: comparable recent deals in the same sector and stage, a multiple of revenue or a forward growth projection, and sometimes a discounted cash flow model for later-stage companies with real financials (Investopedia has good general primers on each). Earlier-stage rounds lean much harder on comparables and investor appetite than on any formula, which is exactly why benchmark data matters — it's the closest thing to a market price a pre-revenue company has.
Common mistakes with pre-money vs post-money
- Dividing investment by pre-money instead of post-money, which overstates the founders' remaining ownership.
- Treating a SAFE's valuation cap as if it were a pre-money figure, when a post-money-capped SAFE already includes the new money in the cap.
- Forgetting that a new or expanded option pool is usually carved out of the pre-money side, which quietly dilutes existing shareholders more than the headline valuation suggests.
- Quoting a 409A valuation in a fundraising conversation as though it reflects what investors will pay, rather than what it actually is: a strike-price appraisal for options.
- Comparing a discounted SAFE or note's implied valuation to a straight pre-money figure without first converting both to the same post-money basis.
What seed and Series A valuations actually look like in 2025
Benchmarks help more than intuition here, because 'reasonable' valuations move a lot year to year — general market commentary from bodies like NVCA tracks the same broad trend. Carta's Q3 2025 State of Private Markets report, which tracks primary rounds across its cap table platform, put both seed and Series A median pre-money valuations at record highs.
| Stage | Median pre-money valuation | Year-over-year change |
|---|---|---|
| Seed | $16.0M | +14% |
| Series A | $49.3M | Record high |
| Series B (primary) | $118.9M | Up from $102.8M in Q3 2024 |
Two things stand out. First, the jump from seed to Series A is roughly threefold, which is a useful sanity check when you're modelling future dilution rounds ahead of time. Second, all three stages rose year over year — 2025 wasn't a down market for headline valuations, even as deal volume and diligence timelines shifted elsewhere. None of this means your own round should land on these exact numbers. Sector, location, traction and investor appetite move individual deals well away from the median in either direction — a pre-seed SaaS company and a Series A biotech aren't pricing off the same curve. Treat the table as a reference point for the conversation, not a target to negotiate towards.
It's also worth reading the seed figure alongside deal volume, not in isolation. A rising median pre-money valuation combined with fewer total seed deals closing, which is broadly what 2025 looked like, tends to mean capital is concentrating into fewer, larger, more competitive rounds rather than valuations simply drifting upward for everyone. If your own conversations feel harder to close than the headline number suggests they should be, that's consistent with the wider pattern, not a sign you're doing something wrong.
A founder we've seen run this the wrong way round
A seed-stage founder we've seen work through this had agreed a $10,000,000 pre-money valuation for a $2,500,000 raise, and initially modelled the new investor at 2,500,000 ÷ 10,000,000 — 25% — using the pre-money figure as the base. The correct calculation uses the post-money figure of $12,500,000, which puts the investor at 2,500,000 ÷ 12,500,000, or 20%. A five-point gap, on paper, before a single share was issued. It mattered because the founder had been quoting the wrong number to a second investor discussing a parallel SAFE, and the two instruments would have priced inconsistently against each other. Catching it before signing meant one correction in a spreadsheet instead of a renegotiation after the fact.
409A valuation: a different number, a different job
It's tempting to treat a 409A valuation as just another flavour of company valuation, but it answers a completely different question. Your pre-money and post-money valuations are negotiated with investors and set what they pay for preferred stock. A 409A valuation is an independent appraisal — required for US companies under IRS rules — of what your common stock is worth right now, used purely to set a compliant strike price for employee stock options.
Because common stock carries none of the liquidation preferences and other rights preferred stock gets, a 409A valuation almost always comes in well below your fundraising valuation, sometimes by an order of magnitude. That gap is the whole point: it's what gives employee options room to gain value as the company grows. If you're setting up or reviewing an option pool, the 409A number is the one that actually matters for pricing grants — walked through fully in the employee stock option plan guide.
Getting the 409A wrong isn't just an internal modelling error either. Pricing options below fair market value can trigger real tax penalties for the employees holding them under IRS rules, which is why most companies refresh their 409A after every priced round rather than relying on an old figure once the post-money valuation has clearly moved on. A fresh raise is the single most common trigger for a new 409A, precisely because a much higher post-money valuation makes an old, low strike price harder to defend as still reflecting fair value.
Price per share ties it all together
Once you have a post-money valuation and a fully diluted share count, price per share follows directly: post-money ÷ fully diluted shares outstanding. This is the number that actually appears on stock certificates and SAFEs that convert at a fixed price, and it's why fully diluted share count — including the option pool, not just issued shares — matters as much as the valuation itself. Model both together rather than treating valuation and share count as separate questions, since a larger option pool at the same post-money valuation quietly lowers everyone's price per share and ownership percentage.
Take a company with a $10,000,000 post-money valuation and 10,000,000 fully diluted shares: price per share is $1.00. Add a fresh 1,000,000-share option pool top-up before the round closes, without changing the post-money figure, and fully diluted shares rise to 11,000,000 — price per share drops to roughly $0.91. Nobody renegotiated the headline valuation, yet every existing shareholder's stake is worth slightly less per share, because the pool came out of the pre-money side of the table. It's a quiet mechanic, and it's exactly the sort of thing that's easy to miss when you're focused on the pre-money versus post-money number rather than the share count sitting underneath it.
Convertible notes and discount rates use the same logic
Convertible notes complicate things one step further, because they often carry both a valuation cap and a discount rate, and the note converts at whichever gives the investor the better price. A discount rate applies to the valuation of the priced round that eventually triggers conversion, effectively lowering the price per share the note-holder pays relative to new investors. Whether the cap or the discount ends up controlling, the underlying arithmetic is still pre-money plus new money equals post-money — the discount and cap are just two different ways of adjusting which post-money figure the conversion uses.
Pre-money versus post-money isn't a trick question once you've internalised the order: pre-money plus new money equals post-money, and ownership divides against the post-money base, every time. Run your own numbers, including any option pool or SAFE cap changes, through the SAFE calculator before your next term sheet lands, so the percentages you're agreeing to match the ones that actually end up on your capitalisation table.
Frequently asked questions
What's the difference between pre-money and post-money valuation?
Pre-money valuation is what the company is worth immediately before new investment arrives. Post-money valuation is what it's worth immediately after: post-money = pre-money + the amount raised. Investor ownership is always calculated against the post-money figure.
How is post-money valuation calculated?
Add the new investment to the pre-money valuation: post-money = pre-money + investment. For a $1,000,000 raise on an $8,000,000 pre-money valuation, post-money is $9,000,000, and the investor owns 1,000,000 ÷ 9,000,000, or 11.1%.
What is the average seed round valuation?
Carta's Q3 2025 State of Private Markets report puts the median pre-money valuation for new primary seed rounds at $16 million, up 14% year over year and a record high. Actual figures vary widely by sector, location and traction, so treat this as a benchmark, not a target.
Is a 409A valuation the same as a fundraising valuation?
No. A 409A valuation is an independent appraisal of your common stock's fair market value, used to set a compliant strike price for employee stock options under IRS rules. It's typically far lower than your pre-money or post-money fundraising valuation, which is set by negotiation with investors, not by an appraiser.
Why does a SAFE's valuation cap behave like a post-money number?
A post-money SAFE cap already includes the money being raised, so ownership is investment ÷ cap directly, with no addition step. A priced round's pre-money valuation needs the investment added first. Mixing the two up is one of the most common term sheet errors — see SAFE vs priced round for the worked comparison.